Abstract

Lung cancer detection is the process of detecting the presence of lung tumor or abnormalities in the lungs. Early diagnosis is crucial for increasing the chances of patient survival and successful treatment. When compared to X-rays, Computed Tomography (CT) images are more sensitive and are increasingly being used for the diagnosis and screening of lung tumors. They provide complete cross-sectional images of the lungs and it will even detect small lesions. AI and Machine learning (ML) approaches are most commonly employed to analyse medical images (e.g. CT scans) and detect lung cancer. This algorithm can help radiologists identify patterns indicative or subtle abnormalities of cancer. Medical diagnosis, particularly in complex diseases such as lung cancer, frequently involves ambiguity. The diagnostic system can alleviate ambiguity via cross-verifying findings from various sources by fusing multimodal features. Multimodal feature fusion using deep learning (DL) algorithm is an advanced technology that leverages the abilities of deep neural networks to combine data from three different modalities or sources for better robustness in several applications, namely natural language processing, image, and data analysis, etc. This study introduces a Multimodal Feature Fusion using an Optimal Transfer Learning Method for Lung Cancer Detection and Classification (MFFOTL-LCDC) methodology on CT images. The chief objective of the MFFOTL-LCDC methodology is to exploit the feature fusion process for the identification and classification of lung tumor. To attain this, the MFFOTL-LCDC model undergoes a multimodal feature fusion approach to derive feature vectors using 3 DL approaches such as SqueezeNet, CapsNet, and Inception v3 models. Besides, the MFFOTL-LCDC technique applies the remora optimization algorithm (ROA) for the hyperparameter choice of 3 DL models. For lung cancer recognition, the MFFOTL-LCDC algorithm exploits the deep extreme learning machine (DELM) algorithm. A series of simulations were conducted to ensure the greater lung cancer recognition outcomes of the MFFOTL-LCDC methodology. The extensive outcomes determine the improved results of the MFFOTL-LCDC technique over recent DL approaches.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.